1.2K(top 0.1%)
papers
48.0K(top 0.1%)
citations
110(top 0.1%)
h-index
176(top 0.1%)
g-index
1.2K
all documents
50.8K
doc citations
4.1K
citing journals

Top Articles

#TitleJournalYearCitations
1Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell TransplantationNew England Journal of Medicine2000977
2High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidinNature Medicine2007743
3Telomere DiseasesNew England Journal of Medicine2009723
4Mutations inTERT,the Gene for Telomerase Reverse Transcriptase, in Aplastic AnemiaNew England Journal of Medicine2005665
5Chromatin Signatures in Multipotent Human Hematopoietic Stem Cells Indicate the Fate of Bivalent Genes during DifferentiationCell Stem Cell2009548
6Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantationBlood1995493
7Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitroBlood1995491
8Eltrombopag and Improved Hematopoiesis in Refractory Aplastic AnemiaNew England Journal of Medicine2012454
9BONE FORMATION IN VIVO: COMPARISON OF OSTEOGENESIS BY TRANSPLANTED MOUSE AND HUMAN MARROW STROMAL FIBROBLASTSTransplantation1997452
10Bmi1 regulates mitochondrial function and the DNA damage response pathwayNature2009420
11Highly efficient endosomal labeling of progenitor and stem cells with large magnetic particles allows magnetic resonance imaging of single cellsBlood2003404
12International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trialsCytotherapy2016400
13Why Current Publication Practices May Distort SciencePLoS Medicine2008345
14Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trialLancet Oncology, The2015344
15Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignanciesBlood2008337
16Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drugBlood2014336
17High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCTBlood2006333
18Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid LeukemiaCell2018323
19Regulation of CSF1 Promoter by the SWI/SNF-like BAF ComplexCell2001315
20Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cellsBlood2009312
21Cellular Constituents of Immune Escape within the Tumor MicroenvironmentCancer Research2012308
22Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemiaBlood1995306
23Essentials of Th17 cell commitment and plasticityBlood2013306
24ERAD inhibitors integrate ER stress with an epigenetic mechanism to activate BH3-only protein NOXA in cancer cellsProceedings of the National Academy of Sciences of the United States of America2009305
25Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samplesNature2015303
26Targeting B cell receptor signalling in cancer: preclinical and clinical advancesNature Reviews Cancer2018299
27Genotoxicity of Retroviral Integration In Hematopoietic CellsMolecular Therapy2006276
28Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemiaBlood2017276
29Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndromeBlood2003274
30Increased expression of Fas antigen on bone marrow CD34+ cells of patients with aplastic anaemiaBritish Journal of Haematology1995268
31Human ParvovirusesClinical Microbiology Reviews2017258
32Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cellsCytotherapy2009257
33Label-Free Protein Quantification Using LC-Coupled Ion Trap or FT Mass Spectrometry:  Reproducibility, Linearity, and Application with Complex ProteomesJournal of Proteome Research2006244
34Distinct Genomic Integration of MLV and SIV Vectors in Primate Hematopoietic Stem and Progenitor CellsPLoS Biology2004243
35Standardizing Flow Cytometry Immunophenotyping Analysis from the Human ImmunoPhenotyping ConsortiumScientific Reports2016240
36The distribution of T‐cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemiaCancer2019229
37Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemiaBlood2002228
38In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR β-CDR3 sequencingLancet, The2004223
39Aplastic anemiaCurrent Opinion in Hematology2008223
40Bone marrow failure and the telomeropathiesBlood2014222
41Cytotoxic T Lymphocytes Specific for a Nonpolymorphic Proteinase 3 Peptide Preferentially Inhibit Chronic Myeloid Leukemia Colony-Forming UnitsBlood1997216
42Rabbit ATG but not horse ATG promotes expansion of functional CD4+CD25highFOXP3+ regulatory T cells in vitroBlood2008216
43Outcomes and Risks of Granulocyte Colony-Stimulating Factor in Patients With Coronary Artery DiseaseJournal of the American College of Cardiology2005206
44Minimal residual disease prior to allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a meta-analysisHaematologica2017206
45Rituximab in the treatment of acquired factor VIII inhibitorsBlood2002203
46Therapeutic approaches to enhance natural killer cell cytotoxicity against cancer: the force awakensNature Reviews Drug Discovery2015203
47A Spectrum of Severe Familial Liver Disorders Associate with Telomerase MutationsPLoS ONE2009201
48Measurable residual disease testing in acute myeloid leukaemiaLeukemia2017197
49Telomere maintenance and human bone marrow failureBlood2008190
50Deficient CD4+ CD25+ FOXP3+ T regulatory cells in acquired aplastic anemiaBlood2007189